Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs?
Abstract In the field of experimental therapeutics for oncology purposes researchers are continuously evaluating the toxicity of novel treatment approaches against cancer cells. Within this topic of research, it is highly critical to define parameters of toxicity that denote when cancer cells are pe...
Sparad:
| Huvudupphov: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Springer
2024-01-01
|
| Serie: | Discover Oncology |
| Ämnen: | |
| Länkar: | https://doi.org/10.1007/s12672-023-00857-2 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|